HTN Complex
Natural health product licensed in Canada
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80075936
- Status
- Active licence
- Licence date
- 3 March 2017
- Revision date
- 28 December 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 25 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Potassium: up to 125 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 25 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-acétyl-l-cystéine Source : N-acetyl cysteine | 125 mg | Not calculated |
| Crataegus laevigata Source : Crataegus laevigata - Feuille Extraction ratio : 12:1 Dry plant equivalent : 1,200 mg Potency : 2 % Vitexin | 100 mg | Not calculated |
| Zinc Source : Diglycinate de zinc | 3.75 mg | 7,500 µg |
| Punica granatum Source : Seed aril Extraction ratio : 8:1 Dry plant equivalent : 250 mg Potency : 40 % Ellagic acid | 31.25 mg | Not calculated |
| Vanadium Source : Glycinate de nicotinate de vanadium | 25 mcg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 12.5 mg | 25,000 µg |
| Vitamine B6 Source : 5-phosphate de pyridoxal | 12.5 mg | 25,000 µg |
| Folate Source : Folate | 500 mcg | Not calculated |
| Folate Source : L-5-methyltetrahydrofolate | 500 mcg | Not calculated |
| Magnésium Source : Malate de dimagnésium | 50 mg | 100,000 µg |
| Potassium Source : Bicarbonate de potassium | 62.5 mg | 125,000 µg |
| Acide 2-aminoéthanesulfonique Source : Taurine | 125 mg | Not calculated |
| Acide DL-alpha lipoÏque Source : Acide DL-alpha-lipoÏque | 50 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to form red blood cells. Helps in energy metabolism and in tissue formation. Helps to maintain the body's ability to metabolize nutrients. Helps to maintain proper muscle function, including the heart muscle. Source of/An electrolyte for the maintenance of good health. Helps to maintain normal electrolyte balance. Helps to maintain immune function. Helps to maintain normal acid-base metabolism. Helps to maintain normal DNA synthesis. Provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80075936
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.